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Abstract
Mortality models used to assess longevity risk and retirement funding have been extended to stochastic
models with trends and systematic risk. Systematic risk cannot be readily diversified in an insurance pool
or pension fund. It is an important factor in assessing solvency and highlighting the tail risk in longevity
insurance and pension products. Idiosyncratic risk can be diversified in typical pool sizes, although less
effectively at the older ages. Mortality heterogeneity is not usually taken into account in stochastic
mortality models. This is a mortality risk that reduces the effectiveness of idiosyncratic mortality risk
pooling. Heterogeneity has been modeled with frailty models and more recently with Markov multiple
state ageing models. This paper overviews recent developments in models for mortality heterogeneity
and uses a model calibrated to both population mortality and health condition data to consider the impact
of model risk and heterogeneity in assessing solvency and tail risk for longevity risk products.
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Chapter 7
Model Risk, Mortality Heterogeneity, and
Implications for Solvency and Tail Risk
Michael Sherris and Qiming Zhou
Mortality improvements have been systematic in that they have impacted individuals of all ages, although to varying extents by age and across time for many countries. Mortality improvement rates have also shown varying trends (Njenga and
Sherris 2011). Pension funds and insurance companies issuing life annuities have
been exposed to this systematic risk, and this has the potential to impact solvency,
especially in the tail of the distribution of survivors. Although some of this risk has
been transferred to reinsurers using reinsurance and longevity swaps, much of this
risk is accumulating with insurers, pension funds, and reinsurers, and it has not
been diversified into the broader financial markets (Blake et al. 2011).
Systematic longevity risk is usually modeled with a doubly stochastic survival
model, where the mortality rate follows a stochastic process and all individuals of
the same age and gender are assumed to experience the same realized mortality
rate. Given the mortality rate, individual survival is subject only to idiosyncratic
risk, which can be diversified in large pools of lives. Even if there is only idiosyncratic risk, at older ages in the tails of the survival distribution, the number of lives
surviving becomes small and the variability in benefit payments and liability values
increases. This is exacerbated by systematic risk from uncertain but common rates
of improvement across individuals.
Many models of systematic mortality risk have been proposed. These vary from
models such as the Lee–Carter model (Lee and Carter 1992) and variations, to
models that model random changes in a parametric survival curve (Cairns et al.
2006), to those that model the dynamics of mortality rates in a financial framework similar to that used for interest rate models (Biffis 2005). These models do not
include allowance for heterogeneity. Individuals of the same age are assumed to
experience the same aggregate mortality rate.
Increasingly, attention is being devoted to the impact of mortality heterogeneity
and its effect on insurers and pension funds (Lin and Liu 2007; Liu and Lin 2012 ; Su
and Sherris 2012). Along with systematic mortality risk, this mortality heterogeneity has implications for the solvency and tail risk of annuity and pension providers.
Even if there were no systematic, or aggregate, mortality risk, heterogeneity generates variability in future experience and volatility in financial results. Heterogeneity
requires underwriting of risks to avoid adverse selection. Without full information
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about the risks that insurers underwrite, the financial consequences of adverse
selection has its greatest impact for annuities in the tail of the survival distributions
long after the annuities have been issued.
Solvency and tail risk for life annuities and pensions have two dimensions. First,
there is an effect on insurer profitability from adverse experience as well as an
impact on variability at the older ages. Trends in mortality that arise from uncertain mortality improvements and from the deaths of less healthy lives in a heterogeneous pool have their greatest influence at the older ages. Second, the volatility of
financial results arises from both systematic mortality changes, with higher volatility experienced at older ages, and from heterogeneity, also producing higher volatility at older ages (Su and Sherris 2012; Meyricke and Sherris 2013).
There are many different approaches to modeling mortality heterogeneity.
Recent advances have seen the calibration and application of more advanced
models in the form of Markov aging models (Lin and Liu 2007; Liu and Lin 2012;
Su and Sherris 2012) that are extensions of the Le Bras model (1976). The other,
more commonly used, approach is to apply frailty models to capture unobserved
heterogeneity (Vaupel et al. 1979).
In this chapter, we develop and apply a stochastic Markov aging model of heterogeneity that also includes systematic mortality risk, calibrated to population
aggregate mortality and health data. We compare results with a well-known frailty
model and the Le Bras–Markov multiple state model to assess model risk, neither
of which includes systematic mortality risk. These models are used to quantify
solvency and tail risk for a portfolio of life annuities using risk measures standard
deviation and value-at-risk for fund values at the older ages. Results illustrate the
effects of heterogeneity and model risk on the assessment of longevity risk for these
portfolios, as well as the impact of selection and pool size.

Mortality Heterogeneity Models
The main approaches to modeling mortality heterogeneity that we consider are
frailty models and Markov multiple state models. Frailty models treat heterogeneity as unobservable. An often-used frailty model is that of Vaupel et al. (1979),
where an individual is assumed to have frailty Z at age x with force of mortality:
µ ( x , Z ) = Zae bx + c . The frailty factor Z is Gamma distributed Z ~ Gamma (1, σ2 )
so that the average frailty at age x is
a


Z (x ) = 1 + σ2 e bx − 1 


b

(

)

−1

and the average force of mortality is given by µ (x ) = Z (x ) ae bx + c .
The Markov multiple state mortality model was developed by Le Bras (1976),
who used a continuous time Markov chain with an infinite number of states and a
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discrete state space to model senescence. The model starts at state 1 and progresses
to state 2, 3, etc. In any state, the rate of jump to the next higher state and the rate
of death are assumed proportional to the state number. All individuals start in state
0 at time 0. In state i, the transition rate to state i + 1 is λ 0 + i λ , and the transition
to death (an absorbing state) is µ 0 + i µ . For the Le Bras model, the probability of
being in state i at time t is (Yashin et al. 2000):
e − ( λ 0 + µ 0 ) t  λ − λ e − ( λ + µ )t 
Pi (t ) =
λ + µ 
i ! 

i

λ

∏  λ + (k − 1)
i

0

k =1

The probability of survival to time t, given the individual was in state n at time
0, is given by
S n (t ) = e

− ( λ 0 + µ 0 + n ( λ + µ )) t


λ+µ 
 µ + λe − (λ + µ )t 

λ0 + nλ
λ

Yashin et al. (1994) show the representation of the average force of mortality in
the fixed frailty model to be equivalent to the Le Bras model.1 Markov aging models allow for heterogeneity because of the differing mortality rates in the different
states.
There have been several applications of Markov chains to failure time distributions in mortality, also known as phase-type distributions. Lin and Liu (2007)
devised a deterministic survival rate model based on a Markov aging process. Each
state in the model represents a ‘physiological age,’ as opposed to calendar age. The
model assumes that there is a maximum physiological age, n, and that n = 200 is
appropriate as an approximation to the potentially infinite aging process in the Le
Bras model. Subsequently, Su and Sherris (2012) developed the Lin and Liu model
(2007) to assess population heterogeneity for life annuity portfolios and relate states
and mortality rates to aggregate population mortality.
These two Markov aging models have parameters that capture the changes in
observed period life tables. Liu and Lin (2012) make the model stochastic by adding
a time change component. The small number of states and the transition matrix
facilitate the incorporation of health information. The time change allows a probabilistic statement of mortality uncertainty. The initial distribution is estimated from
health condition data, and closed forms for the expected value and variance of the
survival probability exist if the stochastic time change process has a closed form
moment generating function.
These Markov aging models are the basis of the model used in what follows. We
extend the Su and Sherris (2012) approach to include health states calibrated to health
conditions data as well as aggregate population mortality data. We also subordinate
this underlying model to a Gamma time change, so that survival distributions are
stochastic. The underlying model allows an assessment of model risk by comparison
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of results for solvency and tail risk with the other models of heterogeneity. The subordinated model shows the significance of heterogeneity if mortality is stochastic.
The Markov aging model used has a time-inhomogeneous five-state transition matrix fitted to ages 30–110. Transition occurs as a Markov process from one
transient state to its next state, or to the absorbing state, and the model takes into
account both health status and mortality data. Aggregate survival rates are determined by a deterministic underlying multiple states survival model S0 (⋅) and a time
change process γ t . The underlying model assumes the individual mortality process
moves through a series of deteriorating health statuses. Health and mortality is
made stochastic by a random time change. The aggregate survival rate at time t is
St = S 0 ( γ t ) . Time until death in this system has a phase-type representation ( π,T ) ,
where π is the initial distribution on the transient states, and T is the states’ transition rates matrix. The probability of survival up to time x is S0 = π exp (Tx ) e
where e is a column of ones. Under the assumption that deterioration in health is
more likely than improvement, transition is assumed to be acyclic. Since all acyclic
phase-type distributions have a Coxian representation, T can be written as:
 −( λ1,t + q1,t )

0

0


0


0

λ1,t
− ( λ 2 ,t + q 2 ,t )
0
0
0

0
0
λ 2 ,t
0
− ( λ 3 ,t + q 3 ,t )
λ 3 ,t
0
− ( λ 4 ,t + q 4 ,t )
0
0

0
0
0
λ 4 ,t
−q5









where
q1,t = q2,t = q3,t = q4 ,t = a × e bt .
q5,t = a × e bt + c

λ i ,t = mi × (t − 1) + ni

for i = 1… 4

a , b, c , m , n ≥ 0
Here, λ i ,t is the rate of transition from state i to state i +1 at time t, and qi ,t is
the rate of transition from state i to the absorbing (death) state at time t. The time
change is modeled as a Gamma process which is non-decreasing, additive, and has
a closed form moment generating function. It is defined as starting at γ 0 = 0 with
independent increments ( γ t + s − γ t ), which are Gamma distributed with mean s
and variance νs.
The Markov aging model is used in two ways. Its deterministic component (i.e.
the underlying Markov process) is used for comparisons with other deterministic
heterogeneity models. The subordinated model is used to assess the impact of systematic mortality risk.
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Data
Modeling mortality heterogeneity requires a basis to divide the population into
groups of individuals anticipated to experience similar rates of mortality, distinct
from other groups. Calibration of these models requires information about the
health status distribution and survival probability. This can be done using socioeconomic status, health conditions, or health risk factors. Socioeconomic status and
income level are related to mortality, yet the correlation is not definitive and mortality is driven by more specific factors than socioeconomic status. Health risk factors
based on individual panel data can be used to relate failure time to health characteristics of individuals. Characteristics include various factors such as diastolic and
systolic blood pressure, body mass index, cholesterol, blood sugar, vital capacity,
and cigarettes per day. This approach has significant data availability imitations at
a population level.
Health risk factors such as obesity or smoking habits are less effective in capturing heterogeneity than existing health conditions such as heart disease or lung
cancer. In addition, health condition data is more readily available than health risk
factor information, which requires both the risk factor and its duration. The ideal
form of data is that which records a cohort’s experience through time. However,
health data are generally only available for the population alive in a particular year,
so period mortality data must be used to match period health data.
For calibration of the Markov aging model, the data used for estimating severity
of the health conditions and health status distribution were derived from a variety of sources. The National Health Survey (NHS) data (ABS 2009) are used to
capture prevalence of long-term conditions, at ten-year intervals from age 15 to
75, from years 2007–2008. We also use estimated average dementia prevalence by
Ritchie et al. (1992) in five-year age intervals from 60 to 85. The Australian Cancer
Incidence and Mortality Books (ACIMB) (AIHW 2012) are used for cancer incidence and mortality for five-year age intervals up to 85, to the year 2008. Mortality
by cause data (other than cancer) was taken from the following sources: the WHO
mortality database (WHO 2010) for Australia gives the number of deaths from a
health condition, for five-year age intervals until 95, to the year 2006; the Australian
Bureau of Statistics Causes of Death database (ABSCD) (ABS 2013) gives number
of deaths from each condition, aggregate of all ages, to the year 2010. Infectious
diseases or accidents were not taken into account, which means that the calibrated
model assumes all individuals to have the same exposure to these baseline risks.
In order to determine population health status distributions, health conditions
are ranked according to their severity and divided into five groups (or health states);
the distribution of the population for these five health states was estimated from the
prevalence of health conditions. Health conditions are ranked by the probability of
death from cause-of-death data given the prevalence of a condition. Since deaths
by cause from WHO are only available up to 2006, and prevalence is only available
for 2007–2008, the 2006 WHO data are scaled by the ratio of 2008 to 2006 numbers of deaths in ABSCD.
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Some assumptions are made in estimating the proportion of the population in
each health state. It is assumed that the prevalence of a condition for individuals
for a ten-year age range could be used to represent the expected prevalence at the
midpoint age, since health data are available at ten-year intervals, but the model
requires distributions across ages. It is also assumed that long-term conditions are
independent and that for a person affected by more than one condition, the highest death rate among all of the conditions is assumed to be the death rate. The
proportion of individuals with a specific condition as their most severe condition
is assumed equal to the proportion of individuals not affected by any worse condition multiplied by the proportion of the total population affected by the specific
condition.
Aggregate mortality data are taken from the Human Mortality Database (HMD
2013). The 2008 Australian period life table (male and female combined) is used for
coherence with health data.

Calibration of Mortality Heterogeneity Models
Figure 7.1 shows the survival curve for the fitted Le Bras model and the Australian
2008 life table used for calibration. The model provides a better fit to the survival
curve when fitted for ages above 20. The parameter values estimated for the Le
Bras model 20+ are given in Table 7.1. The model is equivalent to the frailty model.
The Markov aging model is fitted using observed health and survival distributions as expected values. The sum of squared differences with the model’s estimation of E (S (t )) is minimized. A lower limit of 0.001 is imposed for ν to prevent a
near zero denominator in the numerical estimation procedure. Other parameters
are assumed to have a lower limit of 0. Parameter estimates for the Markov aging
model are given in Table 7.2.
Figure 7.2 shows the fitted survival curve. Figure 7.3 shows the fitted versus
observed data by the health states for the model. The model provides a good fit to
the survival distribution and health states data used for calibration.

Solvency and Tail Risk
In order to assess solvency and tail risk arising from heterogeneity, a portfolio of
life annuities is projected using simulation. Annuity contracts are assumed to be
written at age 65 under differing assumptions about the health status of the lives
purchasing the annuity. The annuities pay an annual payment of $1 for as long as
the individual lives. Expenses and other costs are not included. The distribution of
health status is generated from each model. For comparison purposes health status
ranges are aggregated into comparable groups for the purpose of calculating premiums and simulating annual balances.
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Panel A. Le Bras fitted to ages 0 to 105.
1.0
0.9
Survival probability

0.8
0.7
0.6
0.5
0.4
0.3
0.2
0.1
0.0

0

5 10 15 20 25 30 35 40 45 50 55 60 65 70 75 80 85 90 95 100 105
Age
Data

Fitted

Panel B. Le Bras fitted to ages 20 to 105.
1.0
0.9
Survival probability

0.8
0.7
0.6
0.5
0.4
0.3
0.2
0.1
0.0

20

25

30

35

40

45

50

55

60 65
Age

Data

70

75

80

85

90

95 100 105

Fitted

Figure 7.1. Survival curve fit of the Le Bras model.
Notes: Figures show the fit of the Le Bras model to the 2008 Australian life table survival curve (male
and female combined). The model provides a better fit to survival data starting from age 20 than that
starting from birth.
Panel A. Le Bras fitted to ages 0–105.
Panel B. Le Bras fitted to ages 20–105.
Source: Authors’ calculations.

Premiums are calculated to be equal to the actuarial expected present value of all
payments. Survival rates conditional on health states are used to allow for selection.
Population average survival rates are used for the cases where no anti-selection is
assumed for mixed health status groups. A fixed interest rate of 3 percent per annum
is assumed along with an assumption of random investment returns.
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Table 7.1 Parameter estimates for Le Bras
Model fitted to ages above 20
λ0
µ0
λ
µ

0.489972
0.000608
0.117869
0.00001

Notes: The table shows the parameters estimates
for the Le Bras model based on the Yashin et al.
parameterization (1994). Parameter definitions
are given in the text.
Source: Authors’ calculations.

Table 7.2 Parameter estimates for subordinated
Markov model fitted to ages 30–110.
a

b
c

m1

n1
m2
n2
m3
n3
m4
n4
ν

0.000022
0.143882
0.907697
0.001753
0.004911
0.000919
0.020675
0.00038
0.046633
0
0.032396
0.146892

Notes: The table shows the parameters estimates for
the subordinated Markov aging model. Parameter
definitions are given in the text.
Source: Authors’ calculations.

Random returns are simulated using a model (including calibration) adopted
directly from Nirmalendran et al. (2012). Assets were assumed allocated according to the Australian Prudential Regulation Authority statistics (APRA 2010) of
5.5 percent in cash, 86.8 percent in bonds, and 7.7 percent in stocks (rebalanced
every year). Cash rates and stock prices are modeled with geometric Brownian
motion. Short rates generated by the Vasicek model are used for single-period bond
returns. For the random returns case, premiums are calculated with discount factor based on bonds yields. However, unlike Nirmalendran et al. (2012), the market
price of investment risk is not included.
The distributions of healthy states for the Markov aging model are given in Table
7.3. These percentages are calibrated to the health data. The table shows the shift
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1.0
0.9

Survival probability

0.8
0.7
0.6
0.5
0.4
0.3
0.2
0.1
0.0

30 35 40 45 50 55 60 65 70 75 80 85 90 95 100 105
Age
2008 Sx

Fitted Sx

Figure 7.2. Survival curve fit of the Markov aging model of heterogeneity based on both
health and survival data.
Note: Figure shows the fit of the Markov aging model used in the chapter compared to the 2008
Australian life table survival curve. The model fit is shown for ages 40 and above.
Source: Authors’ calculations.

from the healthier states to the less healthy states and eventually to the death states
with increase in age. The percentage in the healthiest state diminishes rapidly from
age 50 to 70, with a reduction from 47.5 percent to 14.5 percent. By age 70 the distribution across health states has shifted to the less healthy states with higher mortality.
Figure 7.4 shows the distribution of heterogeneity at age 65 given by the three
models by showing the distribution of expected future lifetimes for the different models. The Vaupel frailty model and the Le Bras Markov model forecast a
higher proportion with higher life expectancies than the Markov aging model. The
Markov aging model reflects a calibration to health status data as well as population
mortality. By not reflecting health status, the expected future lifetime is overstated
in the other models.

Impact of Heterogeneity and Adverse Self-selection
The impact of heterogeneity is illustrated for the three models in Figure 7.5 with a
comparison of a ‘best health’ case and a ‘mixed’ case using the standard deviation
of the fund values in the older ages for a pool size of 1,000 individuals. The best

Panel A. Age 40.
70
65%

64%

60
50

%

40
30

25% 24%

20
7% 7%

10
0

0%
State 1

State 2

State 3
observed
Observed
Fitted

3%

State 4

0%

0%

State 5

Panel B. Age 60.
40

37%
34%

35
29%

30

%

25

25%
18%

20

18%

15

12% 12%

10
5
0

1% 0%
State 1

State 2

State 3
Observed

State 4

State 5

fitted
Fitted

Figure 7.3. Fitted versus observed data for Markov aging model.
Note: Figure shows distribution of health states for the Markov aging model used in the paper compared
to the actual data use dot fit the model. The model fit is shown for ages 40 and 60.
Panel A. Age 40.
Panel B. Age 60.
Source: Authors’ calculations.
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Table 7.3 Markov aging model: Percentage distribution of health states for ages 40–70

Age:
30
40
50
60
70

State: 1(%)

2(%)

3(%)

4(%)

5(%)

Deceased (%)

72.7
65.1
47.5
24.8
14.5

20.5
25.0
31.3
37.3
29.6

5.0
7.4
12.5
18.2
20.4

0.4
0.2
4.7
11.7
18.3

0.0
0.2
0.3
0.9
2.2

1.3
2.1
3.7
7.1
14.9

Notes: The table shows the distribution of health states for varying ages based on the Markov aging
model. Health state 1 is the best health state with the lowest mortality rate, and 5 is the worst health
state with the highest mortality rate.
Source: Authors’ calculations.
Heterogeneity at age 65

70
60

% Population

50
40
30
20
10
0

<10

10~20

20~30

30~40

>40

Future expected lifetime (years)
Vaupel

Le Bras

Markov

Figure 7.4. Heterogeneity based on expected future lifetimes at age 65.
Note: The figure shows the distribution of future expected lifetime according to the three modes
used in the text to quantify heterogeneity of mortality. The Markov model has a noticeably different
distribution from the other models, reflecting its calibration to both health and survival data.
Source: Authors’ calculations.

health case assumes that only individuals in the best health class of the Markov
aging model purchase annuities. The mixed cases assume a portfolio of annuitants
with similar health proportions to that of the population purchases annuities with
an average premium for the group, and there is no selection based on health.
The standard deviation of the annuity pool amount increases with older ages for
all models. Even though frailty models imply reduced relative heterogeneity in

Panel A. Markov model standard deviation.
800

Standard deviation

700
600
500
400
300
200
100
0

25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45
Years since start of contract
Best only

Mixed

Panel B. Le Bras model standard deviation.
700

Standard deviation

600
500
400
300
200
100
0

25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45
Years since start of contract

Best only

Mixed

Figure 7.5. Standard deviation risk measure for the annuity pool amount at older ages for
the different models of heterogeneity for a pool size of 1,000.
Note: The figures show standard deviation of the annuity fund for annuities commencing at age 65
at the older ages for a pool size of 1,000 individuals. The standard deviations are shown for the three
different models and for the assumption that only the best health individuals purchase annuities (best
only), and also assuming a mixture of health states representative of the population purchase annuities
(mixed).
Panel A. Markov model standard deviation.
Panel B. Le Bras model standard deviation.
Panel C. Vaupel model standard deviation.
Source: Authors’ calculations.
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Panel C. Vaupel model standard deviation.
800
700

Standard deviation

600
500
400
300
200
100
0

25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45
Years since start of contract
Best only

Mixed

Figure 7.5. (Continued)

mortality at older ages, there is an increase in variability of pool fund amounts. The
Le Bras and Vaupel models produce similar results, with the Vaupel model producing higher standard deviations.
The most interesting aspect shown here is the Markov aging model, whose
measure of heterogeneity is specifically calibrated to population health data. The
heterogeneity for cases when only people in the best health states purchase annuities is significantly lower than for the mixed-population pool. These differences do
not arise in the other two models, where heterogeneity in health is derived from
aggregate survival rates only.
Figure 7.6 shows the Markov aging model results for the best health state
compared with the mixed health case in order to illustrate the differences in the
expected value of the fund as well as the variability. The best health case expected
value starts higher but both fund values converge to zero, since the premiums are
fair. In the mixed population case the distribution of fund sizes is much wider, with
significantly higher probabilities of adverse fund sizes.2 This illustrates how the
strategy of writing annuities for a select group of individuals reduces the volatility
arising from heterogeneity and is a lower risk strategy for an annuity provider.
In practice individuals can self-select against the annuity provider. This is
referred to as adverse selection. To consider this we assume that the premium
charged is based on the mixed population distribution of health states but individuals purchase annuities based on their health state. Thus lives in better health
than the mixed group find the annuity rate attractive and purchased annuities. As
shown in Figure 7.7, the effect of this anti-selection is that the average fund size

Panel A. Best health state only annuity fund balance.
2,000

Annuity portfolio ($AU)

1,500
1,000
500
0
–500
–1,000
–1,500

25

30
Mean

35
Years since start of contract
±1 standard deviation

40

45

5th percentile

Annuity portfolio ($AU)

Panel B. Mixed population annuity fund balance.
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Figure 7.6. Balance of annuity fund for the best health state and the population mix showing
uncertainty and downside risk.
Note: The figures show the annuity fund for annuities commencing at age 65 at the older ages for a
pool size of 50 individuals. Panel A shows an annuity portfolio with only the best health state and
Panel B shows annuities assuming a mixture of health states representative of the population purchase
annuities (mixed).
Panel A. Best health state only annuity fund balance.
Panel B. Mixed population annuity fund balance.
Source: Authors’ calculations.

Panel A. Mean balance.
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Panel B. Standard deviation.
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Figure 7.7. Mean and standard deviation of balance of annuity fund showing the impact
of adverse selection.
Note: The figures show the annuity fund for annuities commencing at age 65 for a pool size of 50
individuals assuming that a population annuity rate is charged. The top figure shows the mean balance
and the bottom figure the standard deviation. Two cases are shown: one where there is no self (adverse)
selection and the other where only the healthy lives purchase annuities.
Panel A. Mean balance.
Panel B. Standard deviation.
Source: Authors’ calculations.
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Table 7.4 Annuity premiums and tail risk measures assuming a fixed investment return for
different models of heterogeneity
Mortality
model

Heterogeneity

Markov

best health only
state 2
state 3
state 4
state 5
mixed
mixed w/self-selection
best health only
mixed
mixed w/self-selection
best health only
mixed
mixed w/self-selection

Le Bras

Vaupel

Annuity
premium
15.22
14.94
13.97
11.45
0.64
13.42
13.42
17.49
14.15
14.15
18.39
14.72
14.72

Risk measures at age 110
Stdev 95% VaR
511.76
519.94
566.82
687.93
118.03
682.91
540.05
588.21
634.72
608.96
639.50
676.94
656.93

821.67
855.21
922.96
1112.05
199.83
1122.83
5452.06
947.61
1052.37
6816.63
1029.39
1130.14
7369.68

Notes: The table shows the premium for a life annuity of 1 per annum and tail risk measures for a pool
of 1,000 individuals aged 65 assuming different pool compositions for health statuses for a fixed
investment return of 3% per annum. Results are shown for the different deterministic models of
heterogeneity. See text.
Source: Authors’ calculations.

drops significantly, as expected, and the chance of major losses increases. Adverse
selection does produce lower standard deviations of pool fund balances, but this is
primarily because the mean level of the fund falls more rapidly and the self-selected
group is less heterogeneous than the mixed group.
Table 7.4 shows the premiums and risk measures at the ultimate age of 110
for the cases of best health, mixed health, and adverse selection for a pool size of
1,000. Annuity premiums vary significantly according to health state in the Markov
aging model. They vary from 15.22 for the best health state to 0.64 in the worst
health state. The Le Bras and Vaupel models produce higher premiums, reflecting
the higher life expectancy in these models. The three models agree on the impact
of self-selection, although they differ on the reduction in volatility when the best
health group is priced separately. These results illustrate the extent of model risk
in allowing for heterogeneity when assessing a pricing strategy and solvency of an
annuity pool. Large variations in premiums occur as well as in tail measures of risk.

Impact of Random Investment Returns
Table 7.5 shows the annuity premiums and risk measures for pool sizes of 1,000
assuming random investment returns. Premiums are lower since the average interest
rate in the stochastic model is higher than the deterministic 3 percent used in Table
7.4. The best health annuity premium for the Markov aging model is now 12.68,
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Table 7.5 Annuity premiums and tail risk measures assuming random investment returns
for different models of heterogeneity
Mortality
model

Heterogeneity

Markov

best health only
state 2
state 3
state 4
state 5
mixed
mixed w/self-selection
best health only
mixed
mixed w/self-selection
best health only
mixed
mixed w/self-selection

Le Bras

Vaupel

Annuity
premium
12.68
12.49
11.80
9.85
0.63
11.34
11.34
13.93
11.84
11.84
14.35
12.14
12.14

Risk measures at age 110
Stdev 95% VaR
4,570.53
4,454.89
4,250.96
3,494.09
386.70
4,096.90
3,912.58
5,480.72
4,328.60
4,218.89
5,725.39
4,500.81
4,428.48

7,372.69
7,150.40
6,755.93
5,688.37
638.02
6,528.22
17,878.91
9,047.16
6,910.74
19,635.98
9,188.87
7,286.31
20,553.27

Notes: The table shows the premium for a life annuity of 1 per annum and tail risk measures for a pool
of 1,000 individuals aged 65 assuming different pool compositions of health statuses for a random
investment return. Results are shown for the different deterministic models of heterogeneity. See text.
Source: Authors’ calculations.

compared to 13.93 for the Le Bras model and 14.35 for the Vaupel model. Risk is
substantially increased with the addition of investment return risk. The Le Bras and
Vaupel models show similar risk measures for the different cases of selection and
these are higher than the Markov aging model. For the Markov aging model the better health states contribute significantly to the overall fund risk measures.

Impact of Stochastic (Systematic) Mortality
The subordinated Markov aging model incorporates stochastic mortality through
a Gamma time change. This changes the survival probabilities for all individuals
in a random manner. The result is a distribution of survival probabilities for each
health state. The degree of uncertainty in future survival probabilities is determined by the variance ν of the Gamma time change.
Table 7.6 shows the impact of the Gamma time change parameter on the fund
standard deviation at age 110. The annuity fund tail risk is not very sensitive to this
assumption. Higher values of the parameter result in reduced standard deviations
for a mixed health state fund as compared with the best health only case.

Impact of Pool Size
Table 7.7 compares the standard deviation at age 110 for pool sizes 100 to 100,000
given by the Markov aging model with and without the stochastic time change.
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Table 7.6 Standard deviation of annuity fund for
different assumptions of stochastic mortality risk
Stdev at age 110
ν
0.01
0.05
0.1
0.5

Best health
956.16
1,859.89
2,603.98
5,660.73

Mixed
1,027.44
1,817.99
2,509.03
5,474.22

Notes: The table shows the standard deviation for a
life annuity fund of a pool of 1,000 individuals age 65
assuming different pool compositions for health statuses for
annual payments of $1 and a fixed investment return of
3% per annum. See text.
Source: Authors’ calculations.

Table 7.7 Standard deviation at age 110 for different pool sizes using Markov model
without and with stochastic mortality risk
Pool size

Deterministic Markov

Subordinated Markov

100
1,000
10,000
100,000

215.54
684.12
2,147.19
6,832.39

354.96
2,954.66
28,913.66
287,749.89

Notes: The table shows the standard deviation of the fund at age 110 for life annuity of 1 per annum for
best health individuals age 65, assuming a fixed investment return of 3% per annum. The stochastic
model assumes variance of Gamma time change ν = 0.095 . See text.
Source: Authors’ calculations.

With deterministic mortality rates, standard deviation increases approximately in
proportion to the square root of pool size, showing a diversification of idiosyncratic
mortality risk. Thus as the pool size grows by 10 times from 1,000 to 10,000, the
tail risk, as given by the fund standard deviation at age 110, increases by approximately 3.16 times (square root of 10). In contrast, with the inclusion of systematic
risk, the effect of diversification of mortality risk increases by 9.8 times (almost 10).
Systematic mortality risk dominates as the pool size increases.
Figure 7.8 shows how the impact of systematic mortality risk increases through
the older ages. The standard deviation of the pool amount for ages above 90 for
the deterministic and subordinated Markov aging models, for pool sizes 500 and
1,000, increases significantly. The effect of larger pool sizes at the older ages is
clearly seen.

Panel A. Without systematic risk.
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600
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400
300
200
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25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45
Years since start of contract
Pool 500

Pool 1,000

Panel B. With systematic risk.
3,500

Annuity amount ($AU)

3,000
2,500
2,000
1,500
1,000
500
0

25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45
Years since start of contract
Pool 500

Pool 1,000

Figure 7.8. Standard deviation of annuity pool amount at older ages for the Markov aging
model.
Note: The figures show the standard deviation of the annuity fund for annuities of $1 per annum for best
health individuals aged 65, assuming a fixed investment return of 3 percent per annum.
Panel A. Without systematic risk.
Panel B. With systematic risk.
Source: Authors’ calculations.
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Conclusion
This chapter has deployed a recently developed Markov aging model for mortality
heterogeneity, along with more commonly used frailty models, to show the impact
of heterogeneity and systematic mortality risk on annuity fund values at the older
ages, the tail of the mortality distribution. Model risk for longevity arises from a
misspecification of the underlying process being modeled. Systematic mortality
risk models have been developed and applied. Markov aging models for heterogeneity have also been developed. Standard models of heterogeneity do not capture observed health differentials or the effect of systematic mortality risk. Using
a model that captures only one of these aspects of mortality risk has limitations
because of model risk.
We illustrate the impact of this model risk in the determination of annuity premiums and fund risk measures. Heterogeneity results in a wide variation in annuity
premiums depending on health status. Selection of lives in better health states by
insurers when writing life annuities is a less risky strategy than writing annuities on
all health states in the population, even if premium rates vary by health state and
there is no adverse selection. Adverse selection negatively impacts both profitability
and fund risk.
Increasing pool sizes increase tail risk almost linearly with the size of the pool for
the cases where the Markov aging mortality model includes systematic risk. This
effect is not captured by standard models of heterogeneity where mortality pooling
results in only a square root of pool size increase in fund risk.

Notes
1. The two are equivalent when: a = [( λ 0 ) / ( λ )] × µ , b = λ + µ , c = µ 0 − [( λ 0 ) / ( λ )] × µ ,
σ2 = [( λ ) / ( λ 0 )] .
2. The other two models show a smaller magnitude; see Table 7.3.
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